n-acetylneuraminic acid has been researched along with Diabetes Mellitus, Type 2 in 64 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.56) | 18.7374 |
| 1990's | 19 (29.69) | 18.2507 |
| 2000's | 28 (43.75) | 29.6817 |
| 2010's | 14 (21.88) | 24.3611 |
| 2020's | 2 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Biswas, R; Divakar, DD; Fenol, A; Jayachandran, P; Krishnan, S; Kumar, KA; Suresh, R; Vellappally, S | 1 |
| Gomer, RH; Karhadkar, TR; Pilling, D | 1 |
| Ibrahim, MA; Inim, MD; Isah, MB; Onyike, E | 1 |
| Agakov, F; Campbell, H; Gornik, O; Hayward, C; Klaric, L; Lauc, G; Lemmers, RFH; Lieverse, AG; Rudan, I; Sijbrands, EJG; Šimurina, M; Urda, D; van Hoek, M; Vilaj, M; Wilson, JF | 1 |
| Bertrand, KA; Chen, X; Diaz, SL; Eliassen, H; Gregg, CJ; Khaw, KT; Khedri, Z; Luben, R; Nguyen, D; Padler-Karavani, V; Samraj, AN; Sawyer, S; Varki, A; Willett, W; Wu, K; Yu, H | 1 |
| Eguchi, J; Hida, K; Inoue, K; Iseda, I; Katayama, A; Makino, H; Murakami, K; Nakatsuka, A; Ogawa, D; Ogawa, T; Terami, T; Teshigawara, S; Tone, A; Wada, J; Yamada, M | 1 |
| Fujita, T; Fuke, Y; Hemmi, S; Kajiwara, M; Satomura, A; Soma, M; Yabuki, M | 1 |
| Bashir, M; Khan, RU | 1 |
| Chen, X; Shi, X; Zheng, N; Zheng, Y | 1 |
| Anghel, A; Budu, V; Ene, CD; Neagu, M; Nicolae, I; Penescu, M | 1 |
| Duncan, H; Lalloo, S; Maraj, K; Matmungal, V; Matthews, F; Prajapati, B; Samuel, R; Shivananda Nayak, B; Sylvester, P | 1 |
| Bashir, M; Iqbal, M; Khan, R; Malik, SA | 1 |
| Ashrafian, H; Born, GV; Digby, J; Drury, NE; Frenneaux, MP; Howell, NJ; Nassimizadeh, M; Pagano, D | 1 |
| Bashir, M; Idrees, M; Khan, RU; Malik, SA; Rahman, IU | 1 |
| Afshariani, R; Bodagkhan, F; Merat, A; Roozbeh, J; Yarmohammadi, H | 1 |
| Amin, F; Idrees, M; Jan, NU; Khan, MI; Khan, RU; Salman, M; ur Rahman, I | 1 |
| Mahboob, T; Nawab, SN; Shahid, SM; Shaikh, R | 1 |
| Lagundžin, D; Masnikosa, R; Nedić, O | 1 |
| Crook, MA; Duncan, BB; Mengue, SS; Opperman, ML; Reichelt, AJ; Schmidt, MI; Sriharan, M | 1 |
| Abdella, N; Akanji, AO; Al Mohammedi, H; Mojiminiyi, OA; Moussa, MA; Zaki, M | 1 |
| Masuda, H; Wakabayashi, I | 2 |
| Ameerally, P; Crook, MA; Goldsmith, L; Lumb, P; Miell, J; Russell-Jones, D; Singh, N | 1 |
| Croci, G; Curatola, G; Fiorilli, A; Goi, G; Lombardo, A; Massaccesi, L; Mazzanti, L; Segalini, G; Tettamanti, G; Tringali, C; Venerando, B | 2 |
| Ekin, S; Gunduz, H; Meral, I; Mert, N | 2 |
| Car, A; Gavella, M; Lipovac, V; Rakos, R; Sokolić, L; Vucić, M | 1 |
| Mattock, MB; Pickup, JC | 1 |
| Crook, M | 1 |
| Akdogan, M; Budak, Y; Demirci, H; Yavuz, D | 1 |
| Chrostek, L; Cylwik, B; Koput, A; Poplawska, A; Szmitkowski, M | 1 |
| Bhaktha, G; Nayak, SB | 1 |
| Abdella, N; Al-Sheikh, N; Alsaeid, M; Gomez, JE; Moussa, MA; Refai, TM | 1 |
| Pickup, JC | 1 |
| Chrostek, L; Cylwik, B; Jakimiuk, B; Popławska, A; Szmitkowski, M | 1 |
| Faur, L; Moldovan, C; Motocu, M; Muţiu, G; Onaca, M | 1 |
| Byrne, CD; Crook, MA; Englyst, NA; Lumb, P; Masding, MG; Sandeman, DD; Stears, AJ; Wootton, SA | 1 |
| Aral, Y; Yilmaz, FM; Yilmaz, G; Yucel, D | 1 |
| Burt, D; Chusney, GD; Crook, MA; Fitzgerald, AP; Mattock, MB; Pickup, JC | 1 |
| Nacitarhan, S; Ozben, T; Tuncer, N | 1 |
| Orekhov, AN; Sobenin, IA; Tertov, VV | 1 |
| Crook, MA; Pickup, JC; Tutt, P | 1 |
| Chana, T; Mather, HM; Mattock, MB; Pickup, JC; Samuel, A | 1 |
| Chen, J; Deckert, M; Gall, MA; Jensen, JS; Parving, HH; Yokoyama, H | 1 |
| Ishida, H; Kadowaki, S; Matsuda, H; Nosaka, K; Seino, Y; Someya, Y; Sugimoto, C; Suzuki, K; Taguchi, Y | 1 |
| Gylling, H; Melajärvi, N; Miettinen, TA | 1 |
| Couchman, S; Crook, MA; Tutt, P | 1 |
| Curatola, G; Martarelli, D; Mazzanti, L; Rabini, RA; Salvolini, E; Tesei, M; Venerando, B | 1 |
| Allannic, H; Cloarec, L; Durou, MR; Guehenneux, E; Legras, B; Letellier, C; Ruelland, A | 1 |
| Chusney, GD; Kehely, AM; Mather, HM; Pasapula, C; Pickup, JC; Roberts, GA | 1 |
| Burt, D; Chusney, GD; Mattock, MB; Pickup, JC | 1 |
| Jayaraman, M; Ramachandran, A; Snehalatha, C; Vijay, V | 1 |
| Chusney, GD; Islam, N; Kazmi, F; Mattock, MB; Pickup, JC; Zaini, A | 1 |
| Masuda, H; Wakabayashi, I; Wakabayashi, R | 1 |
| Deepa, R; Mohan, V; Rema, M | 1 |
| Chusney, GD; Mattock, MB; Pickup, JC | 1 |
| Crook, MA; Hussain, A; Khandhadia, S; Lumb, P; Ridha, A | 1 |
| Abdella, N; Akanji, AO; Al Assoussi, A; Mojiminiyi, OA; Moussa, M | 1 |
| Burt, D; Chusney, GD; Pickup, JC; Thomas, SM | 1 |
| Crook, MA; Kargbo, S; Lumb, P | 1 |
| Emekli, N; Ipbüker, A; Nokay, S; Yarat, A | 1 |
| Dargel, R; Kopitzsch, S; Oswald, B; Schlag, B; Winkler, L | 1 |
| Nowak, S; Watała, C | 1 |
1 review(s) available for n-acetylneuraminic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Type 2 diabetes mellitus: a disease of the innate immune system? An update.
Topics: Acute-Phase Proteins; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Immunity, Innate; Inflammation; N-Acetylneuraminic Acid; Risk Factors | 2004 |
4 trial(s) available for n-acetylneuraminic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients.
Topics: Adult; Aged; Atherosclerosis; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Endpoint Determination; Fasting; Female; Glucose Tolerance Test; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Momordica charantia; N-Acetylneuraminic Acid; Phytotherapy | 2015 |
Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment.
Topics: Adult; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fruit; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Momordica charantia; N-Acetylneuraminic Acid; Phytotherapy; Plant Preparations; Rosiglitazone; Thiazolidinediones; Triglycerides | 2009 |
A comparison of the effect of glitazones on serum sialic acid in patients with type 2 diabetes.
Topics: Biomarkers; Blood Glucose; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; N-Acetylneuraminic Acid; Pioglitazone; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2012 |
Serum sialic acid and ankle versus brachial arterial-pressure ratio in NIDDM.
Topics: Ankle; Blood Pressure Determination; Brachial Artery; Cholesterol; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Ischemia; Leg; Male; N-Acetylneuraminic Acid | 1998 |
59 other study(ies) available for n-acetylneuraminic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effect of Non-Surgical Periodontal Therapy on the Serum Sialic Acid Levels in Diabetic Patients with Periodontitis.
Topics: Adult; Biomarkers; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Periodontitis | 2019 |
A CD209 ligand and a sialidase inhibitor differentially modulate adipose tissue and liver macrophage populations and steatosis in mice on the Methionine and Choline-Deficient (MCD) diet.
Topics: Adipose Tissue; Animals; Cell Adhesion Molecules; Choline Deficiency; Diabetes Mellitus, Type 2; Disease Models, Animal; Fatty Liver; Inflammation; Lectins, C-Type; Liver; Macrophages; Mice; N-Acetylneuraminic Acid; Neuraminidase; Non-alcoholic Fatty Liver Disease; Receptors, Cell Surface | 2020 |
Variations in the mRNA expression level of UDP-GlcNAc epimerase/ManNAc kinase and neuraminidase 1 genes in organs of type 2 diabetic animals.
Topics: Animals; Brain; Colon; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gene Expression Regulation, Enzymologic; Liver; Multienzyme Complexes; N-Acetylneuraminic Acid; Neuraminidase; Pancreas; Rats, Wistar; Real-Time Polymerase Chain Reaction; Spleen | 2021 |
IgG glycan patterns are associated with type 2 diabetes in independent European populations.
Topics: Aged; Area Under Curve; Diabetes Mellitus, Type 2; Female; Galactose; Glycosylation; Humans; Immunoglobulin G; Male; Middle Aged; N-Acetylneuraminic Acid | 2017 |
Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk.
Topics: Adult; Aged; Antibodies; Atherosclerosis; Autoantigens; Colorectal Neoplasms; Diabetes Mellitus, Type 2; Epitopes; Female; Humans; Middle Aged; N-Acetylneuraminic Acid; Neuraminic Acids; Polysaccharides; Red Meat; Risk Factors | 2018 |
Urinary fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray.
Topics: alpha-2-HS-Glycoprotein; Alpha-Globulins; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Male; Microarray Analysis; Middle Aged; N-Acetylneuraminic Acid; Plant Lectins; Risk | 2013 |
Diminished complement-activating capacity through the classical pathway in sera from type 2 diabetes mellitus.
Topics: Aged; Complement C3; Complement Pathway, Classical; Diabetes Mellitus, Type 2; Female; Humans; Immunoglobulin G; Immunomodulation; Male; Middle Aged; N-Acetylneuraminic Acid; Serum | 2014 |
Relationship between Serum Sialic Acid and Hemostatic Markers in Patients with Type 2 Diabetes Mellitus.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Diabetes Mellitus, Type 2; Female; Fibrinolysis; Humans; Male; Middle Aged; N-Acetylneuraminic Acid | 2015 |
Monitoring Diabetic Nephropathy by Circulating Gangliosides.
Topics: Aged; Albuminuria; Biomarkers; Blood Glucose; Case-Control Studies; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Gangliosides; Glycated Hemoglobin; Humans; Male; Middle Aged; Monitoring, Physiologic; N-Acetylneuraminic Acid; Prospective Studies; Urea | 2016 |
Correlation of microalbumin and sialic acid with anthropometric variables in type 2 diabetic patients with and without nephropathy.
Topics: Adolescent; Adult; Albuminuria; Analysis of Variance; Anthropometry; Biomarkers; Blood Glucose; C-Reactive Protein; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Trinidad and Tobago | 2008 |
Reduced negative surface charge on arterial endothelium explains accelerated atherosclerosis in type 2 diabetic patients.
Topics: Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Ferritins; Glycocalyx; Humans; Mammary Arteries; Microscopy, Electron; N-Acetylneuraminic Acid; Staining and Labeling; Surface Properties | 2010 |
Serum sialic acid changes in type 2 diabetic patients on metformin or rosiglitazone treatment.
Topics: Biomarkers; Blood Glucose; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Male; Metformin; N-Acetylneuraminic Acid; Risk; Risk Factors; Rosiglitazone; Thiazolidinediones; Triglycerides | 2010 |
Significance of serum and urine neuraminidase activity and serum and urine level of sialic acid in diabetic nephropathy.
Topics: Adult; Aged; Analysis of Variance; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Neuraminidase; Young Adult | 2011 |
Glycemic control, dyslipidemia and endothelial dysfunction in coexisted diabetes, hypertension and nephropathy.
Topics: Albuminuria; Blood Glucose; Cholesterol; Creatinine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dyslipidemias; Female; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; N-Acetylneuraminic Acid; Nitric Oxide; Triglycerides; Urea | 2012 |
Posttranslational modifications of the insulin-like growth factor-binding protein 3 in patients with type 2 diabetes mellitus assessed by affinity chromatography.
Topics: Adult; Blood Glucose; Blotting, Western; Boronic Acids; C-Peptide; Case-Control Studies; Chromatography, Affinity; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Glycosylation; Humans; Insulin-Like Growth Factor Binding Protein 3; Lectins; Male; N-Acetylneuraminic Acid; Protein Binding; Protein Processing, Post-Translational; Statistics, Nonparametric | 2012 |
Total sialic acid and associated elements of the metabolic syndrome in women with and without previous gestational diabetes.
Topics: Biomarkers; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Follow-Up Studies; Humans; Hyperglycemia; Linear Models; Metabolic Syndrome; N-Acetylneuraminic Acid; Predictive Value of Tests; Pregnancy | 2002 |
Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus.
Topics: Apolipoproteins; Biomarkers; Blood Glucose; Blood Pressure; C-Reactive Protein; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Homocysteine; Humans; Interleukin-6; Lipoproteins; Male; Middle Aged; Multivariate Analysis; N-Acetylneuraminic Acid; Regression Analysis; Risk Factors | 2002 |
Relation of serum sialic acid to blood coagulation activity in type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Biomarkers; Blood Coagulation; Cohort Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Japan; Male; Middle Aged; N-Acetylneuraminic Acid; Platelet Count; Risk Factors | 2002 |
Serum sialic acid, a possible cardiovascular risk factor is not increased in Fijian Melanesians with impaired glucose tolerance or impaired fasting glucose.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fasting; Female; Fiji; Glucose Tolerance Test; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Risk Factors | 2002 |
Acidic and neutral sialidase in the erythrocytes of patients with type 2 diabetes: an answer to comments by Richard et al.
Topics: Diabetes Mellitus, Type 2; Erythrocyte Aging; Erythrocyte Membrane; Humans; Macrophage Activation; Models, Biological; N-Acetylneuraminic Acid; Neuraminidase; Phagocytosis | 2003 |
Comparative study of total protein, and total and lipid-associated serum sialic acid levels in patients with type 2 diabetes mellitus.
Topics: Biomarkers, Tumor; Blood Glucose; Blood Proteins; Diabetes Mellitus, Type 2; Female; Humans; Lipids; Male; Middle Aged; N-Acetylneuraminic Acid; Reference Values | 2003 |
Serum sialic acid in subjects with impaired glucose tolerance and in newly diagnosed type 2 diabetic patients.
Topics: Biomarkers; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Inflammation; Male; Middle Aged; N-Acetylneuraminic Acid; Patient Selection; Reference Values | 2003 |
Activation of the innate immune system as a predictor of cardiovascular mortality in Type 2 diabetes mellitus.
Topics: Adult; Biomarkers; Cause of Death; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Follow-Up Studies; Humans; London; Male; Middle Aged; N-Acetylneuraminic Acid; Prospective Studies; Risk Factors; Survival Analysis | 2003 |
Serum sialic acid levels and selected mineral status in patients with type 2 diabetes mellitus.
Topics: Case-Control Studies; Cholesterol; Chromium; Copper; Creatinine; Diabetes Mellitus, Type 2; Female; Humans; Iron; Lipid Metabolism; Lipids; Magnesium; Male; Manganese; Middle Aged; N-Acetylneuraminic Acid; Reference Values; Trace Elements; Turkey; Zinc | 2003 |
Erytrocyte membrane anionic charge in type 2 diabetic patients with retinopathy.
Topics: Albuminuria; Alcian Blue; Anions; Blood Glucose; Coloring Agents; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Erythrocyte Membrane; Female; Glycosaminoglycans; Humans; Male; Middle Aged; N-Acetylneuraminic Acid | 2004 |
Age-dependent relation of serum sialic acid concentration to aortic pulse wave velocity in type 2 diabetes.
Topics: Adult; Aged; Aging; Aorta; Blood Flow Velocity; Diabetes Mellitus, Type 2; Humans; Middle Aged; Muscle, Smooth, Vascular; N-Acetylneuraminic Acid; Pulse | 2004 |
Serum sialic acid and carbohydrate-deficient transferrin concentration in Type 2 diabetes mellitus with and without macrovascular complications.
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Transferrin | 2004 |
Relationship between sialic acid and metabolic variables in Indian type 2 diabetic patients.
Topics: Adolescent; Adult; Albuminuria; Asian People; Cholesterol; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Female; Glycated Hemoglobin; Humans; India; Male; Middle Aged; N-Acetylneuraminic Acid; Triglycerides | 2005 |
Factors associated with type 1 diabetes in Kuwaiti children.
Topics: Adolescent; Blood Glucose; Case-Control Studies; Child; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Kuwait; Lipid Metabolism; Logistic Models; Male; N-Acetylneuraminic Acid; Proteins; Risk Factors; Social Environment; Thyroid Diseases | 2005 |
Inflammatory markers and type 2 diabetes.
Topics: Biomarkers; Diabetes Mellitus, Type 2; Humans; Inflammation; Metabolic Syndrome; N-Acetylneuraminic Acid | 2006 |
Serum level of sialic acid (SA) and carbohydrate-deficient transferrin (CDT) in type 2 diabetes mellitus with microvascular complications.
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Microcirculation; Middle Aged; N-Acetylneuraminic Acid; Transferrin | 2006 |
Sialic Acid, possible marker of angiopathic complications at diabetics type 2.
Topics: Aged; Biomarkers; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Humans; Hyperlipidemias; Middle Aged; Myocardial Ischemia; N-Acetylneuraminic Acid; Obesity | 2005 |
Percentage of body fat and plasma glucose predict plasma sialic acid concentration in type 2 diabetes mellitus.
Topics: Adipose Tissue; Aged; Blood Glucose; Body Composition; Body Mass Index; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Humans; Linear Models; Male; Middle Aged; N-Acetylneuraminic Acid; Predictive Value of Tests | 2006 |
Levels of serum sialic acid and thiobarbituric acid reactive substances in subjects with impaired glucose tolerance and type 2 diabetes mellitus.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Thiobarbituric Acid Reactive Substances | 2007 |
Serum sialic acid concentration and coronary heart disease in NIDDM.
Topics: Adult; Age Factors; Apolipoproteins; Blood Glucose; Blood Pressure; Cholesterol; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Humans; Hypertension; Lipoproteins; Male; Middle Aged; Multivariate Analysis; N-Acetylneuraminic Acid; Odds Ratio; Reference Values; Regression Analysis; Sex Characteristics; Sialic Acids; Triglycerides | 1995 |
Plasma and urine sialic acid in non-insulin dependent diabetes mellitus.
Topics: Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Sialic Acids; Statistics as Topic | 1995 |
Characterization of chemical composition of native and modified low density lipoprotein occurring in the blood of diabetic patients.
Topics: Cells, Cultured; Cholesterol; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Lipids; Lipoproteins, LDL; Lysine; N-Acetylneuraminic Acid; Phospholipids; Sialic Acids | 1994 |
Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy.
Topics: Albuminuria; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fructosamine; Hexosamines; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Reference Values; Sialic Acids; Triglycerides | 1993 |
Serum sialic acid concentrations in Asian diabetic patients in the UK.
Topics: Asia; Biomarkers; Blood Glucose; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Pilot Projects; Reference Values; Risk Factors; Sialic Acids; United Kingdom; White People | 1996 |
Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.
Topics: Aged; Albuminuria; Analysis of Variance; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Electrocardiography; Female; Hemoglobin A; Humans; Lipids; Male; Middle Aged; N-Acetylneuraminic Acid; Prevalence; Reference Values; Risk Factors; Sialic Acids; Smoking | 1996 |
The urinary concentration of sialic acid is increased in non-insulin-dependent diabetic patients with microangiopathy: a possible useful marker for diabetic microangiopathy.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Biomarkers; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Proteinuria; Reference Values; Regression Analysis; Sialic Acids | 1995 |
Sialic acids and the metabolism of low density lipoprotein.
Topics: Apolipoproteins B; Blood Specimen Collection; Coronary Disease; Diabetes Mellitus, Type 2; Humans; Kinetics; Lipoproteins, LDL; Male; Middle Aged; N-Acetylneuraminic Acid; Reference Values | 1996 |
Plasma fibrinogen and its relationship to plasma sialic acid in non-insulin-dependent diabetes mellitus.
Topics: Aged; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Middle Aged; N-Acetylneuraminic Acid | 1996 |
Sialic acid, diabetes, and aging: a study on the erythrocyte membrane.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Erythrocyte Membrane; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Sodium-Potassium-Exchanging ATPase | 1997 |
LDL sialic acid content in type 2 diabetic patients.
Topics: Adult; Diabetes Mellitus, Type 2; Female; Humans; Lipoproteins, LDL; Male; Middle Aged; N-Acetylneuraminic Acid | 1997 |
Higher serum sialic acid in women than in men with NIDDM: possible relevance to increased cardiovascular risk in NIDDM women.
Topics: Acute-Phase Reaction; Aged; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Risk Factors; Sex Characteristics | 1997 |
NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.
Topics: Acute-Phase Proteins; Adult; Albuminuria; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Humans; Hydrocortisone; Insulin Resistance; Interleukin-6; Male; Middle Aged; N-Acetylneuraminic Acid; Orosomucoid; Serum Amyloid A Protein | 1997 |
Serum sialic acid on south Indian type 2 diabetic patients with microvascular complications.
Topics: Albuminuria; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; India; Male; Middle Aged; N-Acetylneuraminic Acid; Reference Values | 1998 |
Ethnic differences in correlates of microalbuminuria in NIDDM. The role of the acute-phase response.
Topics: Acute-Phase Reaction; Adult; Aged; Albuminuria; Biomarkers; Blood Pressure; Body Mass Index; Case-Control Studies; China; Cholesterol, HDL; Creatinine; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; India; Malaysia; Male; Middle Aged; N-Acetylneuraminic Acid; Time Factors; Triglycerides | 1998 |
Lack of association between serum sialic acid levels and retinopathy in Type 2 diabetic patients.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; India; Insulin; Male; Middle Aged; N-Acetylneuraminic Acid; Statistics, Nonparametric; Triglycerides | 1998 |
The innate immune response and type 2 diabetes: evidence that leptin is associated with a stress-related (acute-phase) reaction.
Topics: Acute-Phase Reaction; Adult; Biomarkers; Body Mass Index; Diabetes Mellitus, Type 2; Female; Humans; Hydrocortisone; Interleukin-6; Leptin; Male; Middle Aged; N-Acetylneuraminic Acid | 2000 |
No difference in serum sialic acid in type 2 diabetic patients from the United Arab Emirates with and without diabetic retinopathy.
Topics: Aged; Arabs; Asia; Biomarkers; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Europe; Female; Fructosamine; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; United Arab Emirates | 2000 |
Relation of serum total sialic acid concentrations with diabetic complications and cardiovascular risk factors in Kuwaiti Type 2 diabetic patients.
Topics: Albuminuria; Biomarkers; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Creatinine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Electrocardiography; Female; Glycated Hemoglobin; Humans; Kuwait; Lipids; Male; N-Acetylneuraminic Acid; Obesity; Risk Factors; Sex Characteristics; Triglycerides | 2000 |
Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes.
Topics: Acute-Phase Reaction; Diabetes Mellitus, Type 2; Female; Humans; Immunoenzyme Techniques; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; N-Acetylneuraminic Acid; Tumor Necrosis Factor-alpha | 2000 |
Acidic and neutral sialidase in the erythrocyte membrane of type 2 diabetic patients.
Topics: Adult; Case-Control Studies; Diabetes Mellitus, Type 2; Erythrocyte Aging; Erythrocyte Membrane; Erythrocytes; Humans; Hydrogen-Ion Concentration; Middle Aged; N-Acetylneuraminic Acid; Neuraminidase; Phosphatidylinositol Diacylglycerol-Lyase; Type C Phospholipases | 2002 |
Measurement of urine total sialic acid: comparison of an automated ultraviolet enzymatic method with a colorimetric assay.
Topics: Adult; Colorimetry; Diabetes Mellitus, Type 2; Female; Fructose-Bisphosphate Aldolase; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; N-Acetylneuraminic Acid; Neuraminidase; Reference Values; Ultraviolet Rays | 2002 |
Serum nickel levels of diabetic patients and healthy controls by AAS with a graphite furnace.
Topics: Adult; Aged; Aging; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fructosamine; Hemoglobins; Hexosamines; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Nickel; Sialic Acids; Spectrophotometry, Atomic | 1992 |
[The sialylation rate of apolipoprotein E in insulin-dependent (IDDM) and non-insulin-dependent (NIDDM) diabetes mellitus].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Apolipoproteins E; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Sialic Acids | 1990 |
Changes of sialic acid content in cell membranes and plasma in juvenile diabetes mellitus.
Topics: Adolescent; Adult; Child; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Erythrocyte Membrane; Humans; Middle Aged; N-Acetylneuraminic Acid; Sialic Acids | 1986 |